What is NDC 28595-224?

28595-224 is the product NDC for Urimar-T Caps, Methenamine 120 mg/1 + 4 more ingredients capsule, listed with the FDA by Allegis Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Urimar-T Caps (Methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate).

What is the active ingredient?

Methenamine, Sodium phosphate, Monobasic, Monohydrate, Phenyl salicylate, Methylene blue, Hyoscyamine sulfate.

Allegis Pharmaceuticals, LLC, NDC labeler code 28595. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Urimar-T Caps?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Urimar-T Caps NDC 28595-224 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)28595-224Labeler and product segments. Claims need a package NDC.

Product NDC at billing width28595-0224Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
28595-224-60	2859502246028595022460	60 CAPSULE in 1 BOTTLE (28595-224-60)Marketed from Jun 28, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Urimar-T Caps
Generic name (nonproprietary): methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate
Active ingredients: Methenamine — 120 mg/1Sodium phosphate, Monobasic, Monohydrate — 40.8 mg/1Phenyl salicylate — 36.2 mg/1Methylene blue — 10.8 mg/1Hyoscyamine sulfate — .12 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Allegis Pharmaceuticals, LLCNDC labeler code 28595
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jun 28, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Oxidation-Reduction Activity (Mechanism)
Identifiers: Product ID 28595-224_2b39f5ac-ab4e-617a-e063-6294a90a4c48SPL ID 2b39f5ac-ab4e-617a-e063-6294a90a4c48SPL set ID cf7c3d65-11d2-49cd-b207-8ccc6a221fe0RxCUI 2637557, 2640308UNII J50OIX95QV, 593YOG76RN, 28A37T47QO, T42P99266K, F2R8V82B84UPC 0328595224602
Pharmacologic class: Oxidation-Reduction Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N428595022460 followed by a unit qualifier and the quantity

Package 28595-0224-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 26, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE URIMAR-T™ CAPS is indicated for the treatment of symptoms of irritative voiding. Indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. Indicated for the relief of urinary tract symptoms caused by diagnostic procedures.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 28595-224

What is NDC 28595-224?: 28595-224 is the product NDC for Urimar-T Caps, Methenamine 120 mg/1 + 4 more ingredients capsule, listed with the FDA by Allegis Pharmaceuticals, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Urimar-T Caps (Methenamine, sodium phosphate, monobasic, monohydrate, phenyl salicylate, methylene blue, and hyoscyamine sulfate).
What is the active ingredient?: Methenamine, Sodium phosphate, Monobasic, Monohydrate, Phenyl salicylate, Methylene blue, Hyoscyamine sulfate.
Who is the labeler?: Allegis Pharmaceuticals, LLC, NDC labeler code 28595. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Urimar-T Caps?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.